
Actuate Therapeutics, Inc. (NASDAQ:ACTU) Sees Significant Increase in Short Interest
Actuate Therapeutics, Inc. (NASDAQ:ACTU – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 529,786 shares, an increase of 21.1% from the December 15th total of 437,439 shares. Based on an average daily trading volume, of 78,326 [...]










